The Delhi High Court on Friday set aside a government notification in which it had banned Lupin's fixed-dose combination (FDC) drug Gluconorm-30, reported Business Standard.
MSF hopes that Indian Health Ministry will consider issuing a government use license, to encourage manufacturers to continue with phase III clinical trials of PCV13